moxifloxacin has been researched along with prednisolone phosphate in 12 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (prednisolone phosphate) | Trials (prednisolone phosphate) | Recent Studies (post-2010) (prednisolone phosphate) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 121 | 25 | 40 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 11 (91.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Acharya, NR; Glidden, DV; Hong, KC; Lalitha, P; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 2 |
Acharya, NR; Glidden, D; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME | 1 |
Acharya, NR; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Priya, JL; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME | 1 |
Acharya, NR; Esterberg, EJ; Glaser, TS; Lietman, TM; McLeod, SD; Oldenburg, CE; Ray, KJ; Saravanan, S; See, CW; Srinivasan, M; Tu, EY; Zegans, ME | 1 |
Acharya, NR; Greninger, DA; Keenan, JD; Lietman, TM; Mascarenhas, J; McClintic, SM; Srinivasan, M | 1 |
Acharya, NR; Geetha, M; Glidden, D; Karpagam, R; Lietman, TM; McLeod, SD; Oldenburg, CE; Prajna, L; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
Acharya, NR; Borkar, DS; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
Acharya, NR; Glidden, DV; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Whitcher, JP; Zegans, ME | 1 |
Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; McClintic, SM; O'Brien, KS; Oldenburg, CE; Prajna, NV; Rajaraman, R; Ray, KJ; Srinivasan, M | 1 |
10 trial(s) available for moxifloxacin and prednisolone phosphate
Article | Year |
---|---|
The steroids for corneal ulcers trial: study design and baseline characteristics.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Research Design; Treatment Outcome; Visual Acuity | 2012 |
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Nocardia keratitis: clinical course and effect of corticosteroids.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Polymerase Chain Reaction; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
Topics: Administration, Topical; Anti-Infective Agents; Aza Compounds; Bayes Theorem; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Surveys and Questionnaires; Treatment Outcome; Visual Acuity | 2012 |
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Pneumococcal Infections; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 2013 |
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
Topics: Anti-Bacterial Agents; Aza Compounds; Communicable Diseases, Emerging; Cornea; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2013 |
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2014 |
Visual recovery in treated bacterial keratitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Recovery of Function; Visual Acuity | 2014 |
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Prospective Studies; Quinolines; Regression Analysis; Visual Acuity | 2014 |
2 other study(ies) available for moxifloxacin and prednisolone phosphate
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Improvement in corneal scarring following bacterial keratitis.
Topics: Adult; Aged; Aza Compounds; Cicatrix; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pneumococcal Infections; Prednisolone; Pseudomonas Infections; Quinolines; Vision Disorders; Visual Acuity | 2013 |